Carrick Therapeutics raises $60m for novel cancer treatments
The Dublin commence-up elevated $25m in a Collection C round and secured $35m from Pfizer to develop an state-of-the-art breast most cancers procedure. Irish biopharma organization Carrick Therapeutics has elevated $25m in Series C investment decision to…
Re-Vana Therapeutics raises $11.9m to boost eye disease treatment
A spin-out of Queen’s College Belfast, Re-Vana is doing work to boost the therapy of eye health conditions by reducing the need to have for frequent drug administrations. Belfast-based mostly Re-Vana Therapeutics has lifted $11.9m in Collection A funding…
GeneCentric Therapeutics raises $7.5M after Labcorp deal
The Old Well on the UNC-Chapel Hill campus. LEONARD ORTIZ KRT RESEARCH TRIANGLE PARK GeneCentric Therapeutics, a cancer testing company founded on UNC-Chapel Hill technology, has raised $7.5 million from investors and sealed a significant partnership…
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Flexion Therapeutics, Inc. – FLXN
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Flexion Therapeutics, Inc. – FLXN SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Flexion Therapeutics, Inc. – FLXN PR Newswire…
At-home digital therapeutics pass a real-world test
An internet-connected blood pressure cuff and smartphone app helped patients control hypertension over time, a new study finds. Why it matters: The research — the longest and largest published study looking at how a digital therapeutic can help patients…
VC Daily: Expansion Therapeutics Gets $80 Million for RNA-Targeted Drugs
Good day. Biotechnology startup Expansion Therapeutics Inc. has collected $80 million to hunt for oral medicines that make a significant impact on neurodegenerative diseases. Conventionally, medications have targeted disease proteins. Boston-based…